T 
Terumo 4543.T · JPY
Health Care · Health Care Equipment & Supplies · Tokyo Stock Exchange · 🇯🇵 Japan
2,548
+1.90%
Close of 9 Nov 2026, in JPY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in JPY, from our data supplier.
Revenue
¥1.13trn
FY2017FY2026
Net income
¥135.91bn
FY2017FY2026
Free cash flow
¥145.64bn
FY2017FY2026
Shareholders' equity
¥1.58trn
FY2017FY2026
Income statement
Fiscal years
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ¥1.13trn | ¥1.04trn | ¥921.86bn | ¥820.21bn | ¥703.30bn | ¥613.84bn | ¥628.90bn | ¥599.48bn | ¥587.77bn | ¥514.16bn |
| Gross profit | ¥594.68bn | ¥532.78bn | ¥454.17bn | ¥393.84bn | ¥348.75bn | ¥307.17bn | ¥325.05bn | ¥312.20bn | ¥305.63bn | ¥261.26bn |
| Research and development | — | ¥74.22bn | ¥69.06bn | ¥61.58bn | ¥51.84bn | ¥49.10bn | ¥50.62bn | ¥47.68bn | ¥41.34bn | ¥32.38bn |
| Operating income | ¥184.74bn | ¥179.02bn | ¥134.20bn | ¥117.33bn | ¥118.12bn | ¥97.69bn | ¥108.79bn | ¥104.39bn | ¥106.97bn | ¥90.55bn |
| Net income | ¥135.91bn | ¥116.98bn | ¥106.37bn | ¥89.33bn | ¥88.81bn | ¥77.27bn | ¥85.21bn | ¥79.47bn | ¥91.30bn | ¥54.23bn |
| Diluted earnings per share | 92.11 | 79.28 | 71.96 | 60.01 | 59.42 | 52.01 | 57.36 | 53.50 | 61.46 | 36.50 |
Balance sheet
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | ¥2.31trn | ¥1.83trn | ¥1.83trn | ¥1.60trn | ¥1.47trn | ¥1.35trn | ¥1.24trn | ¥1.12trn | ¥1.08trn | ¥1.02trn |
| Cash and short-term investments | ¥280.49bn | ¥222.15bn | ¥206.33bn | ¥187.43bn | ¥205.31bn | ¥201.89bn | ¥167.29bn | ¥124.73bn | ¥168.18bn | ¥105.67bn |
| Total liabilities | ¥727.72bn | ¥459.85bn | ¥504.31bn | ¥491.16bn | ¥461.37bn | ¥494.53bn | ¥486.47bn | ¥422.68bn | ¥530.61bn | ¥530.74bn |
| Debt | — | ¥213.96bn | ¥268.55bn | ¥266.67bn | ¥259.01bn | ¥293.08bn | ¥278.01bn | ¥225.86bn | ¥336.21bn | ¥338.19bn |
| Shareholders' equity | ¥1.58trn | ¥1.37trn | ¥1.33trn | ¥1.11trn | ¥1.01trn | ¥856.66bn | ¥754.81bn | ¥698.03bn | ¥550.31bn | ¥489.45bn |
| Shares outstanding | 1,476m | 1,475m | 1,478m | 1,488m | 1,495m | 1,486m | 1,486m | 1,486m | 1,486m | 1,486m |
Cash flow
Fiscal years
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | ¥230.85bn | ¥210.80bn | ¥146.33bn | ¥117.54bn | ¥141.47bn | ¥121.48bn | ¥117.48bn | ¥93.57bn | ¥114.56bn | ¥80.86bn |
| Capital spending | −¥85.21bn | −¥68.62bn | −¥60.73bn | −¥72.17bn | −¥74.11bn | −¥83.12bn | −¥83.48bn | −¥39.33bn | −¥31.87bn | −¥29.84bn |
| Free cash flow | ¥145.64bn | ¥142.19bn | ¥85.60bn | ¥45.36bn | ¥67.36bn | ¥38.36bn | ¥33.99bn | ¥54.24bn | ¥82.70bn | ¥51.02bn |
| Dividends paid | −¥41.29bn | −¥35.62bn | −¥32.01bn | −¥27.90bn | −¥23.45bn | −¥21.16bn | −¥20.51bn | −¥19.55bn | −¥15.84bn | −¥14.52bn |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ¥311.81bn | ¥300.32bn | ¥296.63bn | ¥274.96bn | ¥259.96bn | ¥263.94bn | ¥263.55bn | ¥250.49bn |
| Gross profit | ¥178.54bn | ¥149.02bn | ¥153.19bn | ¥147.00bn | ¥145.47bn | ¥138.53bn | ¥145.12bn | ¥139.45bn |
| Operating income | ¥68.84bn | ¥34.21bn | ¥47.93bn | ¥49.12bn | ¥53.49bn | ¥37.97bn | ¥48.77bn | ¥46.87bn |
| Net income | ¥70.43bn | ¥26.37bn | ¥32.65bn | ¥35.05bn | ¥41.84bn | ¥18.36bn | ¥35.42bn | ¥29.31bn |
| Diluted earnings per share | 47.73 | 17.87 | 22.13 | 23.76 | 28.36 | 12.44 | 23.96 | 19.83 |
| Cash from operations | ¥74.48bn | ¥88.92bn | ¥39.95bn | ¥69.35bn | ¥32.64bn | ¥66.53bn | ¥43.37bn | ¥65.20bn |
| Capital spending | −¥12.61bn | −¥35.17bn | −¥14.59bn | −¥18.46bn | −¥16.99bn | −¥25.70bn | −¥11.22bn | −¥16.43bn |
| Free cash flow | ¥61.87bn | ¥53.74bn | ¥25.36bn | ¥50.89bn | ¥15.64bn | ¥40.83bn | ¥32.15bn | ¥48.76bn |
| Total assets | ¥2.37trn | ¥2.31trn | ¥2.26trn | ¥1.89trn | ¥1.80trn | ¥1.83trn | ¥1.88trn | ¥1.75trn |
| Cash and short-term investments | ¥314.63bn | ¥280.49bn | ¥238.00bn | ¥217.29bn | ¥204.29bn | ¥222.15bn | ¥212.56bn | ¥194.92bn |
| Debt | ¥179.94bn | ¥379.80bn | ¥299.83bn | ¥159.87bn | ¥69.98bn | ¥182.39bn | ¥30.00bn | ¥174.80bn |
| Shareholders' equity | ¥1.66trn | ¥1.58trn | ¥1.52trn | ¥1.44trn | ¥1.37trn | ¥1.37trn | ¥1.40trn | ¥1.31trn |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 11.3% | 13.0% | 8.0% |
| Operating income | 16.3% | 13.6% | 8.5% |
| Net income | 15.0% | 12.0% | 10.4% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 52.0% | 50.5% | 50.3% | 51.0% |
| Operating margin | 16.8% | 15.7% | 15.9% | 16.4% |
| Net margin | 11.7% | 11.5% | 11.8% | 12.1% |
Valuation history
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 25.9 | 28.6 | 42.5 | 38.5 | 31.5 | 46.7 | 37.6 | 36.3 | 25.3 | 36.6 |
| Price to sales | 3.1 | 3.2 | 4.9 | 4.2 | 4.0 | 5.9 | 5.1 | 4.8 | 3.9 | 3.9 |
Dividends and splits
Per share, in the currency the company pays
Paid for 36 years. Last went ex-dividend on 29 Sept 2026.
| FY2027 | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 18.00 | 43.00 | 24.00 | 21.50 | 18.50 | 15.00 | 14.00 | 13.75 |
- 2-for-1 split · 28 Mar 2024
- 2-for-1 split · 27 Mar 2019
- 2-for-1 split · 27 Mar 2014
- 11-for-10 split · 26 Sept 1989
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.